Patents Represented by Attorney Myriad Gentics IP Department
  • Patent number: 7598253
    Abstract: Conformationally constrained compounds which mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetics have utility in the treatment of cell adhesion-indicated diseases, such as multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: October 6, 2009
    Assignee: Myriad Genetics, Inc.
    Inventors: Michael Kahn, Masakatsu Eguchi, Hwa-Ok Kim, Marcin Stasiak